Supplier News: Bora, PCI, Fareva & More
The latest from CDMOs, CMOs, and suppliers featuring Bora Pharmaceuticals, PCI Pharma Services, Fareva, Zhaoke, Almac, and Tobin Scientific.
Formulation Development/Drug Product Manufacturing
* Bora Pharmaceuticals Adds Filling Line to Mfg Facility
* Fareva, Zhaoke Form Strategic Alliance for CDMO Services in China
General
* PCI Pharma Secures Additional Funding from Bain, Other Investors
* Almac Expands Cold-Chain Capabilities
* Tobin Scientific Opens New Storage Warehouse
Formulation Development/Drug Product Manufacturing
Bora Pharmaceuticals Adds Filling Line to Mfg Facility
Bora Pharmaceuticals has announced a recent investment to install a high-performance filling line from Norden Machinery at its Mississauga, Ontario, manufacturing facility.
The new line expands Bora’s production capabilities, enabling larger volumes at higher speeds with greater flexibility, particularly for dermatologic products. The new Norden filler is the third tube-filling line at the site and is capable of producing approximately 7 million to 15 million units per year, increasing the site’s total production capability to more than 50 million units annually. The line is qualified for PODA and Track and Trace serialization, allowing more than 20+ of Bora’s markets to be packaged on this line.
The system can accommodate a wide range of fill volumes, from 2g to 150g, and further supports scalability in the wide range of manufacturing vessels, specifically for semi solid manufacture that range in size from 2.5Kg to 3600Kg.
Source: Bora Pharmaceuticals
Fareva, Zhaoke Form Strategic Alliance for CDMO Services in China
Fareva, a French CDMO, and Zhaoke, Guangzhao, China-based CDMO, have reached a memorandum of agreement for Zhaoke to become the recommended trusted partner for Fareva’s customers who seek to manufacture pharmaceutical products in China. Zhaoke has a facility in Nansha, Guangzhou, China.
Source: Fareva
General
PCI Pharma Secures Additional Funding from Bain, Other Investors
PCI Pharma Services, a CDMO of drug products and contract packager, reports that it has received a strategic investment co-led by Bain Capital and existing lead investor Kohlber, and supported with significant reinvestment by Mubadala Investment Company. Partners Group will also continue to support the company with a minority investment. Financial terms of the private transaction were not disclosed.
Source: PCI Pharma Services
Almac Expands Cold-Chain Capabilities
Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold-chain capabilities at its global headquarters in Craigavon, Northern Ireland. The investment includes the completion of a purpose-built ultra-low temperature facility which has tripled Almac Clinical Services’ -15°C to -25°C secondary packaging capabilities and doubled ultra-low temperature storage capacity (-60°C to -80°C) in Craigavon.
This investment is part of Almac’s global ongoing program to expand ultra-Low capabilities, including North Carolina and Singapore facilities which have already been completed. Almac has also expanded its cold chain packaging capabilities and increased capacity by more than 60% in the Craigavon facility. The recent developments include an upgraded cold-chain management center with additional 2°C to 8°C secondary production rooms; new label printing and checking suites and new packaging design facilities. This investment significantly expands the company’s global clinical supply.
Source: Almac
Tobin Scientific Opens New Storage Warehouse
Tobin Scientific, a provider of laboratory relocation services, cold-chain transport, and cGMP warehousing has announced the opening of its newest cGMP warehouse in Wilmington, Massachusetts.
The 40,000-square-foot Wilmington-based warehouse features a 32-foot clear height and a high-density ultra-narrow aisle racking system optimized for efficient material handling. It offers dual -20°C cold storage chambers with full redundancy, supported by a building-wide backup power system to ensure uninterrupted operation. This facility is validated to keep the temperature between 15°C and 25°C, maintaining strict environmental conditions consistent with cGMP standards.
Source: Tobin Scientific
